Pages that link to "Q27114666"
Jump to navigation
Jump to search
The following pages link to imatinib mesylate (Q27114666):
Displaying 50 items.
- imatinib (Q177094) (← links)
- accelerated phase chronic myelogenous leukemia (Q268832) (← links)
- ABL proto-oncogene 1, non-receptor tyrosine kinase (Q587961) (← links)
- chronic myeloid leukemia (Q729735) (← links)
- KIT proto-oncogene, receptor tyrosine kinase (Q909409) (← links)
- gastrointestinal system cancer (Q5526839) (← links)
- Platelet derived growth factor receptor beta (Q21108624) (← links)
- Emerging Agents for the Treatment of Advanced, Imatinib-Resistant Gastrointestinal Stromal Tumors: Current Status and Future Directions (Q26799387) (← links)
- ABL1 BCR::ABL T315I (Q27906612) (← links)
- ABL1 BCR::ABL E255K (Q27906817) (← links)
- PDGFRA D842V (Q28371025) (← links)
- ABL1 BCR::ABL F317L (Q28371204) (← links)
- Glivec (Q29005907) (← links)
- ABL1 BCR::ABL F359V (Q29938345) (← links)
- KIT V560D (Q29938447) (← links)
- ABL1 BCR::ABL M244V (Q29938509) (← links)
- ABL1 BCR::ABL L248V (Q29938511) (← links)
- ABL1 BCR::ABL G250E (Q29938513) (← links)
- ABL1 BCR::ABL Q252H (Q29938514) (← links)
- ABL1 BCR::ABL Y253H (Q29938515) (← links)
- ABL1 BCR::ABL D276G (Q29938518) (← links)
- ABL1 BCR::ABL M351T (Q29938520) (← links)
- ABL1 BCR::ABL H396R (Q29938523) (← links)
- ABL1 BCR::ABL F486S (Q29938666) (← links)
- ABL1 BCR::ABL E255V (Q29938702) (← links)
- ABL1 BCR::ABL F359C (Q29938707) (← links)
- ABL1 BCR::ABL L384M (Q29938714) (← links)
- ABL1 BCR::ABL V299L (Q29938716) (← links)
- ABL1 BCR::ABL L387F (Q29938717) (← links)
- Gastrointestinal stromal tumors. Current data (Q30908551) (← links)
- PDGFRA V561D (Q32948348) (← links)
- ABL1 BCR::ABL E355G (Q32964883) (← links)
- ABL1 BCR::ABL F359I (Q32965008) (← links)
- ABL1 BCR::ABL Q300R (Q32965023) (← links)
- ABL1 BCR::ABL E453A (Q32965059) (← links)
- ABL1 BCR::ABL V379I (Q32965324) (← links)
- ABL1 BCR::ABL A397P (Q32965334) (← links)
- ABL1 C475V (Q32965441) (← links)
- ABL1 BCR::ABL N336S (Q32965445) (← links)
- ABL1 G340L (Q32965507) (← links)
- Spotlight on imatinib mesylate in chronic myeloid leukemia (Q33360949) (← links)
- Expression of c-kit receptor in human cholangiocarcinoma and in vivo treatment with imatinib mesilate in chimeric mice (Q34012590) (← links)
- Imatinib mesylate (Gleevec/Glivec) a molecular-targeted therapy for chronic myeloid leukaemia and other malignancies (Q35810475) (← links)
- Use and limitations of imatinib mesylate (Glivec), a selective inhibitor of the tyrosine kinase Abl transcript in the treatment of chronic myeloid leukaemia (Q35834634) (← links)
- A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338 (Q36435548) (← links)
- Imatinib mesilate for the treatment of gastrointestinal stromal tumour (Q37142082) (← links)
- Imatinib mesylate: an innovation in treatment of autoimmune diseases (Q38129108) (← links)
- Complete response achieved in a case of gastric gastrointestinal stromal tumor by administration of imatinib mesilate with concurrent relatively high-dose steroid therapy to control side effects (Q40343169) (← links)
- Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptor. (Q40455282) (← links)
- Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitro (Q40571040) (← links)